Purchase Order 68HE0B24P0458
Award Date 4/18/24
Potential Completion Date 4/20/24
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27711, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Food and Drug Administration (FDA) awarded a firm fixed price purchase order to Certara UK Limited, doing business as Certara, a for-profit limited liability company, for SIMCYP software licenses and maintenance support. The $114,316.00 contract will allow the FDA's Office of Clinical Pharmacology Drug Reviewers to complete their review of investigational new drugs. Certara has previously provided this physiologically-based pharmacokinetic modeling software to the FDA and...
- This firm-fixed price purchase order contract was awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Certara UK LIMITED, doing business as Certara, a for-profit limited liability company. The $164,400 contract provides annual licenses and maintenance support for Certara's SIMCYP physiologically-based pharmacokinetic modeling software. The software is used by the FDA's Office of Clinical Pharmacology to review submissions from pharmaceutical sponsors,...
- The U.S. Food and Drug Administration (FDA) awarded a $144,000.00 firm-fixed-price purchase order contract to Certara UK LIMITED, doing business as Certara, for the purchase of SIMCYP software. SIMCYP is a physiologically-based pharmacokinetic (PBPK) modeling software used to simulate drug absorption, distribution, metabolism, and excretion processes, which is crucial for optimizing drug development and facilitating regulatory reviews. This contract is not set aside for any specific business...
- The Food and Drug Administration awarded a firm fixed-price purchase order to Certara UK LIMITED (doing business as Certara) on September 6, 2023, for SIMCYP software licenses with a ceiling value of $815,948. The contract will be performed in Great Britain, United Kingdom, and is scheduled for ultimate completion by September 20, 2028. No set-aside designation was applied to this award. Certara provides physiologically-based pharmacokinetic (PBPK) modeling software that simulates drug...
- This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Certara USA Inc., a leading provider of biosimulation software and consulting services. The contract, valued at $16,441.10, is for the procurement of software licenses for Certara's proprietary modeling and simulation tools, including Phoenix WinNonlin, Certara Phoenix, CHEMOFFICE, and SEND EXPLORER. These software products enable federal scientists and reviewers to conduct...
- This federal contract awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Certara USA Inc., doing business as Tripos (DE), is for $83,806.57 to provide Certara Phoenix software licenses for pharmacokinetic modeling and simulation. The contract is a firm fixed-price purchase order with a completion date of August 31, 2026. Certara is a technology-enabled drug development and drug safety consultancy that has received numerous prior federal contract...
- This $11,660 firm fixed-price purchase order contract was awarded to Certara USA Inc. by the National Institutes of Health (NIH) Clinical Center, a civilian agency. The contract is for the procurement of software licenses and subscriptions for Certara's proprietary modeling and simulation tools, which enable federal scientists and reviewers to conduct clinical pharmacology, pharmacometric, and regulatory review analyses on data submitted by industry sponsors. Certara USA Inc. is a leading global...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order to Certara USA Inc., doing business as Tripos (De), to provide annual licenses and maintenance for the Phoenix Quantum software suite. The $151,470.39 award does not have a set-aside designation. Certara, a technology-enabled drug development and drug safety consultancy, has previously received federal contracts from the FDA, NIH, and CDC to provide pharmacokinetic modeling and...
- This federal contract award to Certara USA Inc., doing business as Tripos (De), is for the provision of SEND Explorer Plus software licenses and annual maintenance services to the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services. The $129,832.56 firm fixed-price purchase order has a period of performance through September 29, 2025. Certara is a technology-enabled drug development and drug safety consultancy that specializes in...
- This federal contract award, valued at $45,776, was made by the Centers for Disease Control and Prevention (CDC) to Certara USA Inc., doing business as Tripos (De). The contract provides for the licensing and implementation of Certara's Phoenix software for pharmacokinetic and pharmacodynamic modeling and simulation to support the CDC's public health decision-making. Certara is a technology-enabled drug development and drug safety consultancy that specializes in accelerating medicines to...